Cat. No. | Product name | CAS No. |
DCC1698 |
Dcn1-ubc12 Inhibitor Dn-2
Novel potent and selective DCN1-UBC12 inhibitor for anticardiac fibrotic effects, specifically targetinbg DCN1 at molecular and cellular levels, effectively reversing angiotensin (Ang) II-induced cardiac fibroblast activation |
|
DCC1699 |
Dc-prc2in-01
Novel PRC2 Inhibitor, Targeting EZH2-EED Interaction |
|
DCC1700 |
Dc-s100
Novel, Selective Histone Methyltransferase SET7 Inhibitor |
178803-91-3 |
DCC1701 |
Dc-s238
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor |
832109-48-5 |
DCC1702 |
Dc-s239
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor |
303141-21-1 |
DCC1703 |
Dc-teadin02
Novel potent and selective TEAD autopalmitoylation inhibitor, inhibiting TEADs transcription activity and downstream gene expression |
|
DCC1704 |
Dcz3112
Novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction |
|
DCC1705 |
Dd-04-015
Novel selective BTK degrader, demonstrating prolonged pharmacodynamic effects |
|
DCC1706 |
Dd04107
Featured
Novel inhibitor of α-calcitonin gene-related peptide (α-CGRP) exocytotic release from primary sensory neurons, selectively interacting with Synaptotagmin 1 |
1202877-06-2 |
DCC1707 |
Ddc4002
First-generation allosteric EGFR inhibitor, binding to the allosteric site of EGFR along with ATP that leads to inhibition of cell proliferation and arrest of EGFR L858R/T790M/C797S signalling |
|
DCC1708 |
Ddd00015314
Novel activator of the GUS reporter activity, specific increasing in stumpy reporter gene expression |
893161-97-2 |
DCC1709 |
Ddd01035881
Novel transmission blocker of antimalarials, targeting male gametes |
1396858-56-2 |
DCC1710 |
Ddd-028
Potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain |
1538586-09-2 |
DCC1711 |
Ddd100097
Potent inhibitor of Trypanosoma brucei N-myristoyltransferase (TbNMT) with markedly improved blood-brain barrier permeability |
1215012-74-0 |
DCC1712 |
Ddhctp Sodium Salt
Novel potent and broad-spectrum antiviral agent, acting as a chain terminator for viral RNA polymerase |
|
DCC1713 |
Ddo-2117
Novel potent blocker of mixed lineage leukemia 1 (MLL1)-WDR5 interaction, inhibiting MLL1 complex H3K4 methyltransferase activity |
|
DCC1714 |
Ddo-2213
Novel Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 (MLL1) Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia |
|
DCC1715 |
Ddo-7132
Novel NQO1 substrate, inhibiting cancer cell (NQO1-rich A549 cell line) growth |
|
DCC1716 |
Ddo-7204
Novel Nrf2 activator |
|
DCC1717 |
ddpm-1457
Potent mGAT4 inhibitor |
1392206-92-6 |
DCC1718 |
Ddr1-in-2
Potent and selective DDR1 receptor tyrosine kinase inhibitor |
1315329-35-1 |
DCC1719 |
Ddri-18
Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin |
4402-18-0 |